Insight Molecular Diagnostics Inc. (IMDX) › Shareholders' EquityInsight Molecular Diagnostics Inc. (IMDX) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2013: $3.62M2014: -$1.07M2015: $10.42M2016: $9.86M2017: $4.40M2018: $3.42M2019: $30.84M2020: $33.48M2021: $65.22M2022: $34.29M2023: $20.47M2024: -$12.27M2025: -$31.46M-$31.46M2013Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025-$31.46M-156.3%2024-$12.27M-160.0%2023$20.47M-40.3%2022$34.29M-47.4%2021$65.22M+94.8%2020$33.48M+8.6%2019$30.84M+800.9%2018$3.42M-22.3%2017$4.40M-55.4%2016$9.86M-5.3%2015$10.42M+1069.9%2014-$1.07M-129.7%2013$3.62M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share